Revvity Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.14 M
as on 16-11-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -8.43%
(FY 2023)
- Profit -49.16%
(FY 2023)
- Ebitda -33.50%
(FY 2023)
- Net Worth 10.64%
(FY 2023)
- Total Assets -7.89%
(FY 2023)
About Revvity Health Sciences
The Corporate was formerly known as Perkinelmer Health Sciences Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.14 M, as per Ministry of Corporate Affairs (MCA) records.
Seshadri Suresh, John Healy, Alok Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100TN2009PTC072319
- Company No.
072319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2009
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Revvity Health Sciences Private Limited offer?
Revvity Health Sciences Private Limited offers a wide range of products and services, including Analyzers & Analytical Instruments, Spectrophotometer.
Who are the key members and board of directors at Revvity Health Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayashree Thacker  | Director | 31-Mar-2015 | Current |
| Seshadri Suresh | Director | 04-Sep-2009 | Current |
John Healy  | Director | 15-Dec-2009 | Current |
| Alok Kumar | Director | 16-Nov-2011 | Current |
Financial Performance and Corporate Structure Insights of Revvity Health Sciences.
Revvity Health Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.43% decrease. The company also saw a substantial fall in profitability, with a 49.16% decrease in profit. The company's net worth Soared by an impressive increase of 10.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Revvity Health Sciences?
In 2023, Revvity Health Sciences had a promoter holding of 91.21% and a public holding of 8.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Revvity Healthcare (India) Private LimitedActive 20 years 8 monthsAlok Kumar and Jayashree Thacker are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Revvity Health Sciences?
Revvity Health Sciences has a workforce of 90 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Revvity Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revvity Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
